Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antiandrogenic agents in early development at Yamanouchi

March 10, 2004

N-Myristoyltransferase inhibitors: Potential anticancer agents

March 10, 2004

Ipsen acquires Sterix

March 10, 2004

Pivotal trial planned for pixantrone for relapsed, aggressive NHL

March 10, 2004

KOS-862 studied in combination with Gemzar for advanced solid tumors

March 9, 2004

Canadian approval for one- and three-month Eligard products

March 8, 2004

Yakult Honsha files Japanese import application for oxaliplatin

March 8, 2004

Ultrafine completes scale-up of PPA-605 and PPA-904

March 8, 2004

Boehringer Ingelheim claims new TK inhibitors for cancer and other proliferative disorders

March 5, 2004

New KSP inhibitors in early development at Cytokinetics

March 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...